关注
Hassan Abolhassani
标题
引用次数
引用次数
年份
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ...
The lancet 396 (10258), 1204-1222, 2020
78092020
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ...
The lancet 396 (10258), 1223-1249, 2020
56882020
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic …
H Wang, KM Abbas, M Abbasifard, M Abbasi-Kangevari, H Abbastabar, ...
The Lancet 396 (10258), 1160-1203, 2020
12592020
Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …
JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ...
JAMA oncology 8 (3), 420-444, 2022
10942022
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
C Abbafati, DB Machado, B Cislaghi, OM Salman, M Karanikolos, ...
Deakin University, 2020
10472020
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease …
S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, ...
The Lancet gastroenterology & hepatology 5 (1), 17-30, 2020
9172020
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ...
The Lancet 402 (10397), 203-234, 2023
7092023
Five insights from the global burden of disease study 2019
CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ...
The Lancet 396 (10258), 1135-1159, 2020
6202020
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global …
R Lozano, N Fullman, JE Mumford, M Knight, CM Barthelemy, C Abbafati, ...
The Lancet 396 (10258), 1250-1284, 2020
5402020
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
A Etemadi, S Safiri, SG Sepanlou, K Ikuta, C Bisignano, R Shakeri, ...
The lancet Gastroenterology & hepatology 5 (1), 42-54, 2020
5032020
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ...
The Lancet 400 (10352), 563-591, 2022
4292022
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3422021
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global …
KR Paulson, AM Kamath, T Alam, K Bienhoff, GG Abady, J Abbas, ...
The Lancet 398 (10303), 870-905, 2021
3312021
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
GBD Collaborators, J Ärnlöv
The Lancet 396 (10258), 1223-1249, 2020
3132020
Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase δ syndrome: the european society for immunodeficiencies-activated phosphoinositide 3-kinase δ …
ME Maccari, H Abolhassani, A Aghamohammadi, A Aiuti, O Aleinikova, ...
Frontiers in immunology 9, 543, 2018
2902018
IgA deficiency: correlation between clinical and immunological phenotypes
A Aghamohammadi, T Cheraghi, M Gharagozlou, M Movahedi, N Rezaei, ...
Journal of clinical immunology 29, 130-136, 2009
2822009
Selective IgA deficiency: epidemiology, pathogenesis, clinical phenotype, diagnosis, prognosis and management
R Yazdani, G Azizi, H Abolhassani, A Aghamohammadi
Scandinavian journal of immunology 85 (1), 3-12, 2017
2312017
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
N Sherina, A Piralla, L Du, H Wan, M Kumagai-Braesch, J Andréll, ...
Med 2 (3), 281-295. e4, 2021
2102021
Spectrum of Phenotypes Associated with Mutations in LRBA
OK Alkhairy, H Abolhassani, N Rezaei, M Fang, KK Andersen, ...
Journal of clinical immunology 36, 33-45, 2016
2102016
Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis
H Abolhassani, MS Sadaghiani, A Aghamohammadi, HD Ochs, N Rezaei
Journal of clinical immunology 32, 1180-1192, 2012
2102012
系统目前无法执行此操作,请稍后再试。
文章 1–20